Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Nolan

Showing results (31-40 of 104) with videos related to

Pageof 11
Sort By:
Frontiers in Immunology|March 16, 2026
Correction: VEXAS: A review of current understandings and emerging treatment strategiesRobert Holden, Yogeshraj Jeelall, Andrew McLean-Tooke, et al.
Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association|January 5, 2023
Editorial Commentary: Blood Flow Restriction Therapy Prior to Anterior Cruciate Ligament Reconstruction: Small Effects Require Accurate MeasurementsMark P Cote, David Nolan, Sean Hazzard, et al.
Pharmacogenomics|December 16, 2005
Predicting and diagnosing abacavir and nevirapine drug hypersensitivity: from bedside to bench and back againAnnalise Martin, David Nolan, Coral-Ann Almeida, et al.
Scandinavian Journal of Pain|November 16, 2019
Are there differences in lifting technique between those with and without low back pain? A systematic reviewDavid Nolan, Kieran O'Sullivan, Chris Newton, et al.
Immunity & Ageing : I & A|October 6, 2015
The immunological footprint of CMV in HIV-1 patients stable on long-term ARTJacquita S Affandi, Jacinta Montgomery, Samantha J Brunt, et al.
Physiological Reports|June 11, 2025
Inflammatory and vascular biomarkers as predictors of all-cause death and cardiovascular outcomes in an Australian community-based cohortSilvia Lee, Alison Castley, Matthew Knuiman, et al.
Plos One|December 30, 2014
Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: a changing paradigm for routine HIV laboratory monitoring?Alison Castley, Cassandra Berry, Martyn French, et al.
Plos One|June 30, 2016
Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk FactorsAlison Castley, Leah Williams, Ian James, et al.
Sports Medicine - Open|September 21, 2023
Integrating Deloading into Strength and Physique Sports Training Programmes: An International Delphi Consensus ApproachLee Bell, Ben William Strafford, Max Coleman, et al.
Heart, Lung & Circulation|September 11, 2019
The Utility of Whole Body <sup>18</sup>F-FDG PET-CT in Diagnosing Isolated Cardiac Sarcoidosis: The Western Australian Cardiac Sarcoid StudyLauren Giudicatti, James Marangou, David Nolan, et al.
Pageof 11

Showing results (31-40 of 104) with videos related to

Sort By:
Pageof 11
Frontiers in Immunology|March 16, 2026
Correction: VEXAS: A review of current understandings and emerging treatment strategiesRobert Holden, Yogeshraj Jeelall, Andrew McLean-Tooke, et al.
Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association|January 5, 2023
Editorial Commentary: Blood Flow Restriction Therapy Prior to Anterior Cruciate Ligament Reconstruction: Small Effects Require Accurate MeasurementsMark P Cote, David Nolan, Sean Hazzard, et al.
Pharmacogenomics|December 16, 2005
Predicting and diagnosing abacavir and nevirapine drug hypersensitivity: from bedside to bench and back againAnnalise Martin, David Nolan, Coral-Ann Almeida, et al.
Scandinavian Journal of Pain|November 16, 2019
Are there differences in lifting technique between those with and without low back pain? A systematic reviewDavid Nolan, Kieran O'Sullivan, Chris Newton, et al.
Immunity & Ageing : I & A|October 6, 2015
The immunological footprint of CMV in HIV-1 patients stable on long-term ARTJacquita S Affandi, Jacinta Montgomery, Samantha J Brunt, et al.
Physiological Reports|June 11, 2025
Inflammatory and vascular biomarkers as predictors of all-cause death and cardiovascular outcomes in an Australian community-based cohortSilvia Lee, Alison Castley, Matthew Knuiman, et al.
Plos One|December 30, 2014
Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: a changing paradigm for routine HIV laboratory monitoring?Alison Castley, Cassandra Berry, Martyn French, et al.
Plos One|June 30, 2016
Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk FactorsAlison Castley, Leah Williams, Ian James, et al.
Sports Medicine - Open|September 21, 2023
Integrating Deloading into Strength and Physique Sports Training Programmes: An International Delphi Consensus ApproachLee Bell, Ben William Strafford, Max Coleman, et al.
Heart, Lung & Circulation|September 11, 2019
The Utility of Whole Body <sup>18</sup>F-FDG PET-CT in Diagnosing Isolated Cardiac Sarcoidosis: The Western Australian Cardiac Sarcoid StudyLauren Giudicatti, James Marangou, David Nolan, et al.
Pageof 11